(Q64151815)
Statements
A Randomized, Active-Controlled, Open-Label, Flexible-Dose Study to Assess the Safety and Tolerability of Topiramate as Monotherapy Compared With Levetiracetam as Monotherapy in Pediatric Subjects With New or Recent-Onset Epilepsy (English)
0 references
6 October 2014
0 references
30 November 2021
0 references
282
0 references
2 year
0 references
15 year
0 references